Crossmark

The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant

Crossref DOI link: https://doi.org/10.1038/s41408-023-00920-9

Published Online: 2023-09-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zanwar, Saurabh https://orcid.org/0000-0001-5074-8453
Jacob, Eapen K.

Greiner, Carl

Pavelko, Kevin https://orcid.org/0000-0001-7555-1315
Strausbauch, Michael

Anderson, Emilie

Arsana, Arini

Weivoda, Megan

Shah, Mithun Vinod https://orcid.org/0000-0002-5359-336X
Kourelis, Taxiarchis https://orcid.org/0000-0001-8573-9434
License Information

Text and Data Mining valid from 2023-09-26

Version of Record valid from 2023-09-26
More Information

Article History

Received: 12 June 2023

Revised: 22 August 2023

Accepted: 1 September 2023

First Online: 26 September 2023

Competing interests

: MVS reports institutional research funding from Bristol-Meyers Squibb, AbbVie, Astellas, and MRKR Therapeutics. The remaining authors do not have any relevant conflicts of interest to disclose.

Document is current

Any future updates will be listed below